1. Merck and Sanofi both buying smaller cancer oncology companies at big premiums — The latest from ASH2019 conference — Biopharma Dive’s drug launch of the year: Zolgensma — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Dynasplint

Anonymous board for Dynasplint


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    9
    Views:
    4,399
  2. anonymous
    Replies:
    0
    Views:
    895
  3. Concerned Citizen
    Replies:
    3,926
    Views:
    625,927
  4. Anonymous
    Replies:
    7
    Views:
    5,240
  5. Anonymous
    Replies:
    50
    Views:
    27,641
  6. Anonymous
    Replies:
    8
    Views:
    6,703
  7. Anonymous
    Replies:
    0
    Views:
    2,741
  8. Anonymous
    Replies:
    11
    Views:
    5,821
  9. Anonymous
    Replies:
    2
    Views:
    3,462
  10. Anonymous
    Replies:
    2
    Views:
    3,800
  11. Anonymous
    Replies:
    4
    Views:
    3,630
  12. Anonymous
    Replies:
    113
    Views:
    43,802
  13. Anonymous
    Replies:
    0
    Views:
    3,269
  14. Anonymous
    Replies:
    1
    Views:
    3,743
  15. Anonymous
    Replies:
    14
    Views:
    7,596
  16. Anonymous
    Replies:
    60
    Views:
    28,810
  17. Anonymous
    Replies:
    6
    Views:
    3,573
  18. Anonymous
    Replies:
    0
    Views:
    3,150
  19. Anonymous
    Replies:
    3
    Views:
    3,401
  20. Anonymous
    Replies:
    0
    Views:
    3,129

Thread Display Options

Loading...